Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""CD4 Lymphocyte Count"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 13216
Tytuł:
Immune reconstruction effectiveness of combination antiretroviral therapy for HIV-1 CRF01_AE cluster 1 and 2 infected individuals.
Autorzy:
Li K; Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, People's Republic of China.; State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Chen H; Guangxi Key Laboratory of Major Infectious Disease Prevention and Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, People's Republic of China.
Li J; Guangxi Key Laboratory of Major Infectious Disease Prevention and Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, People's Republic of China.
Feng Y; State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Lan G; Guangxi Key Laboratory of Major Infectious Disease Prevention and Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, People's Republic of China.
Liang S; Guangxi Key Laboratory of Major Infectious Disease Prevention and Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, People's Republic of China.
Liu M; School of Public Health, Guangxi Medical University, Nanning, People's Republic of China.
Rashid A; School of Medicine, Nankai University, Tianjin, People's Republic of China.
Xing H; State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Shen Z; Guangxi Key Laboratory of Major Infectious Disease Prevention and Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, People's Republic of China.
Shao Y; Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, People's Republic of China.; State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.; Guangxi Key Laboratory of Major Infectious Disease Prevention and Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, People's Republic of China.
Pokaż więcej
Źródło:
Emerging microbes & infections [Emerg Microbes Infect] 2022 Dec; Vol. 11 (1), pp. 158-167.
Typ publikacji:
Journal Article
MeSH Terms:
CD4 Lymphocyte Count*
Immune Reconstitution*
Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
HIV Infections/*immunology
HIV-1/*genetics
Adult ; Antiretroviral Therapy, Highly Active ; CD4-Positive T-Lymphocytes/immunology ; Female ; Genotype ; HIV Envelope Protein gp120/chemistry ; HIV Envelope Protein gp120/metabolism ; HIV Infections/virology ; HIV-1/classification ; Humans ; Male ; Middle Aged ; Peptide Fragments/chemistry ; Peptide Fragments/metabolism ; Receptors, CXCR4/chemistry ; Receptors, CXCR4/metabolism ; Retrospective Studies ; Viral Tropism
Czasopismo naukowe
Szczegóły
Tytuł:
Quality of T-Cell Response to SARS-CoV-2 mRNA Vaccine in ART-Treated PLWH.
Autorzy:
Tortellini, Eeva (AUTHOR)
Zingaropoli, Maria Antonella (AUTHOR)
Mancarella, Giulia (AUTHOR)
Marocco, Raffaella (AUTHOR)
Carraro, Anna (AUTHOR)
Jamhour, Meriem (AUTHOR)
Barbato, Christian (AUTHOR)
Guardiani, Mariasilvia (AUTHOR)
Dominelli, Federica (AUTHOR)
Pasculli, Patrizia (AUTHOR)
Napoli, Anna (AUTHOR)
Gaeta, Aurelia (AUTHOR)
Mengoni, Fabio (AUTHOR)
Zuccalà, Paola (AUTHOR)
Belvisi, Valeria (AUTHOR)
Kertusha, Blerta (AUTHOR)
Parente, Alberico (AUTHOR)
Del Borgo, Cosmo (AUTHOR)
Vullo, Vincenzo (AUTHOR)
Ciardi, Maria Rosa (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Molecular Sciences. Dec2022, Vol. 23 Issue 23, p14988. 14p.
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study.
Autorzy:
Kiyingi M; Department of Medicine, Makerere University College of Health Sciences, Makerere University, Box 7062, Kampala, Uganda. .; Makerere University Joint AIDS Program, Makerere University, Kampala, Uganda. .
Nankabirwa JI; Department of Medicine, Makerere University College of Health Sciences, Makerere University, Box 7062, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda.
Sekaggya-Wiltshire C; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
Nangendo J; Department of Medicine, Makerere University College of Health Sciences, Makerere University, Box 7062, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda.
Kiweewa JM; Education Department, Fairfield University, Fairfield, CT, USA.
Katahoire AR; Child Health and Development Center, Makerere University, Kampala, Uganda.
Semitala FC; Department of Medicine, Makerere University College of Health Sciences, Makerere University, Box 7062, Kampala, Uganda.; Makerere University Joint AIDS Program, Makerere University, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2023 Jan 16; Vol. 23 (1), pp. 40. Date of Electronic Publication: 2023 Jan 16.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/diagnosis
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Acquired Immunodeficiency Syndrome*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Adult ; Female ; Male ; Cross-Sectional Studies ; Uganda/epidemiology ; Antiretroviral Therapy, Highly Active ; CD4 Lymphocyte Count
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Using a surrogate with heterogeneous utility to test for a treatment effect.
Autorzy:
Parast L; Department of Statistics and Data Sciences, University of Texas at Austin, Austin, Texas, USA.
Cai T; Department of Biostatistics, Harvard University, Boston, Massachusetts, USA.
Tian L; Department of Biomedical Data Science, Stanford University, Stanford, California, USA.
Pokaż więcej
Źródło:
Statistics in medicine [Stat Med] 2023 Jan 15; Vol. 42 (1), pp. 68-88. Date of Electronic Publication: 2022 Nov 13.
Typ publikacji:
Journal Article
MeSH Terms:
Computer Simulation*
Humans ; Biomarkers ; CD4 Lymphocyte Count
Czasopismo naukowe
Szczegóły
Tytuł:
Association between serum amylase levels and CD4 cell counts in newly diagnosed people living with HIV: A case-control study.
Autorzy:
Jin Y; Department of Internal Medicine, Ningbo Yinzhou No.2 Hospital, Ningbo, People's Republic of China.
Yang T
Xia T
Shen Z
Ma T
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2023 Jan 13; Vol. 102 (2), pp. e32638.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/complications
HIV Infections*/drug therapy
Opportunistic Infections*/complications
Humans ; HIV ; Case-Control Studies ; CD4 Lymphocyte Count ; Amylases
Czasopismo naukowe
Szczegóły
Tytuł:
Tobacco, alcohol, cannabis, and illicit drug use and their association with CD4/CD8 cell count ratio in people with controlled HIV: a cross-sectional study (ANRS CO3 AQUIVIH-NA-QuAliV).
Autorzy:
Devos S; Univ. Bordeaux, INSERM, BPH, U1219, 146, rue Léo Saignat-CS61292, 33076, Bordeaux Cedex, France.; CHU de Bordeaux, COREVIH Nouvelle Aquitaine, INSERM, U1219, 1 Rue Jean Burguet, 33000, Bordeaux, France.
Bonnet F; Univ. Bordeaux, INSERM, BPH, U1219, 146, rue Léo Saignat-CS61292, 33076, Bordeaux Cedex, France.; CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, INSERM, U1219, 1 Rue Jean Burguet, 33000, Bordeaux, France.; Univ. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-P 1401, 146, rue Léo Saignat-CS61292, 33076, Bordeaux Cedex, France.
Hessamfar M; Univ. Bordeaux, INSERM, BPH, U1219, 146, rue Léo Saignat-CS61292, 33076, Bordeaux Cedex, France.; CHU de Bordeaux, COREVIH Nouvelle Aquitaine, INSERM, U1219, 1 Rue Jean Burguet, 33000, Bordeaux, France.; CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, INSERM, U1219, 1 Rue Jean Burguet, 33000, Bordeaux, France.
Neau D; CHU de Bordeaux, Service des Maladies Infectieuses et Tropicales, INSERM, U1219, Pl. Amélie Raba Léon, U121933000, Bordeaux, France.
Vareil MO; Centre Hospitalier de la Côte Basque, Service de Maladies Infectieuses, 13 Avenue de l'interne Jacques Loëb, BP 8, 64109, Bayonne Cedex, France.
Leleux O; Univ. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-P 1401, 146, rue Léo Saignat-CS61292, 33076, Bordeaux Cedex, France.
Cazanave C; CHU de Bordeaux, Service des Maladies Infectieuses et Tropicales, INSERM, U1219, Pl. Amélie Raba Léon, U121933000, Bordeaux, France.
Rouanes N; Centre Hospitalier de Périgueux, Service de Médecine Polyvalente, 80 Av. Georges Pompidou, 22400, Périgueux, France.
Duffau P; CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, INSERM, U1219, 1 Rue Jean Burguet, 33000, Bordeaux, France.; Univ. Bordeaux, Department of Immunology, CNRS, ImmunoConcEpT, UMR 5164, 33000, Bordeaux, France.
Lazaro E; CHU de Bordeaux, Service de Médecine Interne, 1 Avenue de Magellan, 33600, Pessac, France.
Dabis F; Univ. Bordeaux, INSERM, BPH, U1219, 146, rue Léo Saignat-CS61292, 33076, Bordeaux Cedex, France.; CHU de Bordeaux, COREVIH Nouvelle Aquitaine, INSERM, U1219, 1 Rue Jean Burguet, 33000, Bordeaux, France.
Wittkop L; Univ. Bordeaux, INSERM, BPH, U1219, 146, rue Léo Saignat-CS61292, 33076, Bordeaux Cedex, France.; Univ. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-P 1401, 146, rue Léo Saignat-CS61292, 33076, Bordeaux Cedex, France.; Univ. Bordeaux, INSERM, INRIA, BPH, U1219, 146, rue Léo Saignat-CS61292, 33076, Bordeaux Cedex, France.; CHU de Bordeaux, Service d'information médicale, INSERM, U1219, 146, rue Léo Saignat-CS61292, 33076, Bordeaux Cedex, France.
Barger D; Univ. Bordeaux, INSERM, BPH, U1219, 146, rue Léo Saignat-CS61292, 33076, Bordeaux Cedex, France. .
Pokaż więcej
Corporate Authors:
ANRS CO3-AQUIVIH-NA-QuAliV
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Jan 09; Vol. 23 (1), pp. 16. Date of Electronic Publication: 2023 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
Cannabis*
HIV Infections*/drug therapy
Substance-Related Disorders*/complications
Illicit Drugs*
Anti-HIV Agents*/therapeutic use
Humans ; Cross-Sectional Studies ; Tobacco ; Ethanol ; Inflammation/complications ; CD8-Positive T-Lymphocytes ; Viral Load ; CD4 Lymphocyte Count
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance.
Autorzy:
Salata RA; Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH, 44122, USA. .
Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.
Ritz J; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Collier AC; University of Washington, Seattle, WA, USA.
Hogg E; Social & Scientific Systems, A DLH Company, MD, Silver Spring, USA.
Gross R; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Godfrey C; NIAID, Bethesda, MD, USA.
Kumarasamy N; YR Gaitonde Center for AIDS Research and Education, Chennai, India.
Kanyama C; University of North Carolina Project-Malawi, Lilongwe, Malawi.
Mellors JW; University of Pittsburgh, Pittsburgh, PA, USA.
Wallis CL; Lancet Laboratories and BARC SA, Johannesburg, South Africa.
Hughes MD; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Pokaż więcej
Corporate Authors:
ACTG A5288 Study Team
Źródło:
AIDS research and therapy [AIDS Res Ther] 2023 Jan 05; Vol. 20 (1), pp. 3. Date of Electronic Publication: 2023 Jan 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
Humans ; Female ; Adult ; Male ; Reverse Transcriptase Inhibitors/therapeutic use ; Reverse Transcriptase Inhibitors/adverse effects ; Protease Inhibitors/therapeutic use ; Antiretroviral Therapy, Highly Active ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Viral Load ; RNA ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Incidence of Allergic Drug Eruption due to Cotrimoxazole in HIV-Positive Individuals with CD4 ≤200 Cells/ul.
Autorzy:
Rosali I; Department of General Medicine, St. Carolus Hospital, Jakarta, Indonesia.
Virgayanti PS; Department of Dermatovenereology, St. Carolus Hospital, Jakarta, Indonesia.
Marta DS; Department of General Medicine, St. Carolus Hospital, Jakarta, Indonesia.
Danudirgo EW; Department of Internal Medicine, St. Carolus Hospital, Jakarta, Indonesia.
Hadinata S; Department of General Medicine, St. Carolus Hospital, Jakarta, Indonesia.
Pokaż więcej
Źródło:
Journal of the International Association of Providers of AIDS Care [J Int Assoc Provid AIDS Care] 2023 Jan-Dec; Vol. 22, pp. 23259582221146946.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/drug therapy
HIV Seropositivity*/drug therapy
Tuberculosis*/drug therapy
Humans ; Male ; Female ; Trimethoprim, Sulfamethoxazole Drug Combination/adverse effects ; Retrospective Studies ; Incidence ; CD4 Lymphocyte Count
Czasopismo naukowe
Szczegóły
Tytuł:
Spectrum and mortality of opportunistic infections among HIV/AIDS patients in southwestern China.
Autorzy:
Meng S; The Fourth People's Hospital of Nanning, Nanning, 530023, Guangxi, China.
Tang Q; Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Xie Z; The Fourth People's Hospital of Nanning, Nanning, 530023, Guangxi, China.
Wu N; The Fourth People's Hospital of Nanning, Nanning, 530023, Guangxi, China.
Qin Y; The Fourth People's Hospital of Nanning, Nanning, 530023, Guangxi, China.
Chen R; Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Chen X; The Fourth People's Hospital of Nanning, Nanning, 530023, Guangxi, China.
Chen X; Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Li Y; Joint Laboratory for Emerging Infections Diseases in China (Guangxi)-ASEAN, Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi, China.
Shi M; Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Ye L; Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Liang H; Joint Laboratory for Emerging Infections Diseases in China (Guangxi)-ASEAN, Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi, China.
Jiang J; The Fourth People's Hospital of Nanning, Nanning, 530023, Guangxi, China. .; Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi, China. .
Zhou B; Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi, China. .
Lin J; The Fourth People's Hospital of Nanning, Nanning, 530023, Guangxi, China. .
Pokaż więcej
Źródło:
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2023 Jan; Vol. 42 (1), pp. 113-120. Date of Electronic Publication: 2022 Nov 21.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/complications
HIV Infections*/epidemiology
HIV Infections*/diagnosis
AIDS-Related Opportunistic Infections*/epidemiology
AIDS-Related Opportunistic Infections*/diagnosis
Acquired Immunodeficiency Syndrome*/complications
Coinfection*/epidemiology
Coinfection*/complications
Humans ; Cohort Studies ; Retrospective Studies ; China/epidemiology ; CD4 Lymphocyte Count
Czasopismo naukowe
Szczegóły
Tytuł:
Clinical predictors of efavirenz-based regimen treatment durability: A two-year case-control study of antiretroviral-naïve patients.
Autorzy:
Fahrni ML; Department of Clinical Pharmacy, Faculty of Pharmacy, Universiti Teknologi MARA (UiTM), Selangor Branch, Puncak Alam Campus, Selangor Darul Ehsan, Malaysia; Collaborative Drug Discovery Research (CDDR) Group, Communities of Research (Pharmaceutical and Life Sciences), Universiti Teknologi MARA (UiTM), Selangor Darul Ehsan, Malaysia. Electronic address: .
Misran NFL; Department of Clinical Pharmacy, Faculty of Pharmacy, Universiti Teknologi MARA (UiTM), Selangor Branch, Puncak Alam Campus, Selangor Darul Ehsan, Malaysia.
Abidin ZZ; Department of Clinical Pharmacy, Faculty of Pharmacy, Universiti Teknologi MARA (UiTM), Selangor Branch, Puncak Alam Campus, Selangor Darul Ehsan, Malaysia.
Chidambaram SK; Infectious Disease Unit, Medical Department, Sungai Buloh Hospital, Ministry of Health Malaysia, Malaysia.
Lazzarino AI; Faculty of Medicine, School of Public Health, Imperial College London, London, United Kingdom.
Pokaż więcej
Źródło:
Journal of infection and public health [J Infect Public Health] 2023 Jan; Vol. 16 (1), pp. 96-103. Date of Electronic Publication: 2022 Dec 07.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-HIV Agents*/adverse effects
Substance Abuse, Intravenous*/drug therapy
HIV Infections*/drug therapy
Opportunistic Infections*/drug therapy
Drug-Related Side Effects and Adverse Reactions*
Humans ; Case-Control Studies ; Retrospective Studies ; CD4 Lymphocyte Count ; Anti-Retroviral Agents/therapeutic use ; Viral Load ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Tytuł:
Prevalence and factors associated with late diagnosis among older adults living with HIV in liuzhou, China: 2010-2020.
Autorzy:
Chu Q; Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, PR China.; Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Medical University, Hefei, Anhui, PR China.
Zhang X; Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, PR China.; Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Medical University, Hefei, Anhui, PR China.
Lan J; Liuzhou Center for Disease Control and Prevention, Liuzhou, Guangxi Zhuang Autonomous Region, PR China.
Zhang Q; Hefei Center for Disease Control and Prevention, Hefei, Anhui, PR China.
Wei T; Liuzhou Center for Disease Control and Prevention, Liuzhou, Guangxi Zhuang Autonomous Region, PR China.
Fu Y; Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, PR China.; Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Medical University, Hefei, Anhui, PR China.
Fan Y; Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, PR China.; Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Medical University, Hefei, Anhui, PR China.
Pokaż więcej
Źródło:
Journal of medical virology [J Med Virol] 2023 Jan; Vol. 95 (1), pp. e28288. Date of Electronic Publication: 2022 Nov 16.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/diagnosis
HIV Infections*/epidemiology
HIV Seropositivity*
Female ; Humans ; Male ; Aged ; Middle Aged ; HIV ; Delayed Diagnosis ; Prevalence ; China/epidemiology ; CD4 Lymphocyte Count ; Risk Factors
Czasopismo naukowe
Szczegóły
Tytuł:
Late diagnosis of HIV infection in Warsaw: Estimating the scale of the problem and demographic trends.
Autorzy:
Puła J; Department of Infectious Diseases for Adults, Medical University of Warsaw, Warsaw, Poland.; Hospital for Infectious Diseases, Warsaw, Poland.
Kowalska J; Department of Infectious Diseases for Adults, Medical University of Warsaw, Warsaw, Poland.; Hospital for Infectious Diseases, Warsaw, Poland.
Paciorek M; Department of Infectious Diseases for Adults, Medical University of Warsaw, Warsaw, Poland.; Hospital for Infectious Diseases, Warsaw, Poland.
Bednarska A; Department of Infectious Diseases for Adults, Medical University of Warsaw, Warsaw, Poland.; Hospital for Infectious Diseases, Warsaw, Poland.
Skrzat-Klapaczyńska A; Department of Infectious Diseases for Adults, Medical University of Warsaw, Warsaw, Poland.; Hospital for Infectious Diseases, Warsaw, Poland.
Horban A; Department of Infectious Diseases for Adults, Medical University of Warsaw, Warsaw, Poland.; Hospital for Infectious Diseases, Warsaw, Poland.
Pokaż więcej
Źródło:
HIV medicine [HIV Med] 2023 Jan; Vol. 24 (1), pp. 75-81. Date of Electronic Publication: 2022 Jun 06.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/diagnosis
HIV Infections*/epidemiology
Sexual and Gender Minorities*
Male ; Humans ; Female ; Homosexuality, Male ; Delayed Diagnosis ; Risk Factors ; CD4 Lymphocyte Count ; Demography
Czasopismo naukowe
Szczegóły
Tytuł:
Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: a diagnostic accuracy study.
Autorzy:
Huerga H; Department of Field Epidemiology, Epicentre, Paris, France. Electronic address: .
Bastard M; Department of Field Epidemiology, Epicentre, Paris, France.
Lubega AV; Department of Medicine, Epicentre, Mbarara, Uganda.
Akinyi M; Department of Medicine, Médecins Sans Frontières, Nairobi, Kenya.
Antabak NT; Department of Medicine, Médecins Sans Frontières, Maputo, Mozambique.
Ohler L; Department of Medicine, Médecins Sans Frontières, Eshowe, South Africa.
Muyindike W; Department of Medicine, Mbarara Regional Referral Hospital, Mbarara, Uganda.
Taremwa IM; Laboratory of Mycobacteriology, Epicentre, Mbarara, Uganda.
Stewart R; Department of Medicine, Médecins Sans Frontières, Eshowe, South Africa.
Bossard C; Department of Field Epidemiology, Epicentre, Paris, France.
Nkosi N; Department of Medicine, Médecins Sans Frontières, Eshowe, South Africa.
Ndlovu Z; Southern African Medical Unit, Médecins Sans Frontières, Cape Town, South Africa.
Hewison C; Department of Medicine, Médecins Sans Frontières, Paris, France.
Stavia T; National Tuberculosis and Leprosy Control Services, Ministry of Health, Kampala, Uganda.
Okomo G; Department of Health Services, Ministry of Health, Homa Bay, Kenya.
Ogoro JO; National Tuberculosis and Leprosy Control Services, Ministry of Health, Nairobi, Kenya.
Ngozo J; KwaZulu-Natal Department of Health, Durban, South Africa.
Mbatha M; King Cetswayo District Office, Department of Health, Eshowe, South Africa.
Aleny C; National STI, HIV/AIDS Control Program, Ministry of Health, Maputo, Mozambique.
Wanjala S; Department of Medicine, Médecins Sans Frontières, Nairobi, Kenya.
Musoke M; Department of Medicine, Médecins Sans Frontières, Nairobi, Kenya.
Atwine D; Department of Medicine, Epicentre, Mbarara, Uganda.
Ascorra A; Department of Research, Epicentre, Paris, France.
Ardizzoni E; Mycobacteriology Unit, Institute of Tropical Medicine, Antwerp, Belgium.
Casenghi M; Department of Innovation and New Technology, Elizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland.
Ferlazzo G; Southern African Medical Unit, Médecins Sans Frontières, Cape Town, South Africa.
Nakiyingi L; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Gupta-Wright A; Institute for Global Health, University College London, London, UK.
Bonnet M; Université de Montpellier, TransVIHMI, INSERM, IRD, Montpellier, France.
Pokaż więcej
Źródło:
The Lancet. Global health [Lancet Glob Health] 2023 Jan; Vol. 11 (1), pp. e126-e135.
Typ publikacji:
Journal Article
MeSH Terms:
Tuberculosis*/diagnosis
Tuberculosis*/urine
Mycobacterium tuberculosis*
HIV Infections*/complications
HIV Infections*/diagnosis
Humans ; Female ; Male ; CD4 Lymphocyte Count ; Sensitivity and Specificity ; Lipopolysaccharides/urine ; African People ; South Africa
Czasopismo naukowe
Szczegóły
Tytuł:
Differences in Reasons for Late Presentation to HIV Care in Uganda Among Men and Women.
Autorzy:
Lofgren SM; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, 689 23rd Avenue S.E., Minneapolis, MN, 55455, USA. .; Infectious Diseases Institute, Makerere University, Kampala, Uganda. .
Tsui S; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
Natala N; Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, MN, USA.
Nakasujja N; Department of Psychiatry, Makerere University, Kampala, Uganda.
Sebuliba R; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
Ndyetukira JF; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
Arinda A; Infectious Diseases Institute, Makerere University, Kampala, Uganda.; Department of Psychiatry, Makerere University, Kampala, Uganda.
Akinyange V; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
Hullsiek KH; Division of Biostatistics, University of Minnesota, School of Public Health, Minneapolis, MN, USA.
Nalintya E; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
Sadiq A; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
Pastick KA; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, 689 23rd Avenue S.E., Minneapolis, MN, 55455, USA.
Stadleman A; Division of Biostatistics, University of Minnesota, School of Public Health, Minneapolis, MN, USA.
Meya D; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
Boulware DR; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, 689 23rd Avenue S.E., Minneapolis, MN, 55455, USA.
Pokaż więcej
Źródło:
AIDS and behavior [AIDS Behav] 2023 Jan; Vol. 27 (1), pp. 303-313. Date of Electronic Publication: 2022 Aug 02.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/diagnosis
HIV Infections*/epidemiology
Humans ; Male ; Female ; Uganda/epidemiology ; CD4 Lymphocyte Count ; Social Support ; Delayed Diagnosis
Czasopismo naukowe
Szczegóły
Tytuł:
Accuracy of point-of-care HIV and CD4 field testing by lay healthcare workers in the Botswana Combination Prevention Project.
Autorzy:
Bile EC; US Centers for Disease Control and Prevention Botswana (CDC Botswana), Gaborone, Botswana.
Bachanas PJ; US Centers for Disease Control and Prevention Atlanta, United States.
Jarvis JN; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Maurice F; US Centers for Disease Control and Prevention Botswana (CDC Botswana), Gaborone, Botswana.
Makovore V; US Centers for Disease Control and Prevention Botswana (CDC Botswana), Gaborone, Botswana.
Chebani L; US Centers for Disease Control and Prevention Botswana (CDC Botswana), Gaborone, Botswana.
Jackson KG; US Centers for Disease Control and Prevention Atlanta, United States.
Birhanu S; US Centers for Disease Control and Prevention Atlanta, United States.
Maphorisa C; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Mbulawa MB; US Centers for Disease Control and Prevention Botswana (CDC Botswana), Gaborone, Botswana.
Alwano MG; US Centers for Disease Control and Prevention Botswana (CDC Botswana), Gaborone, Botswana.
Sexton C; US Centers for Disease Control and Prevention Atlanta, United States.
Modise SK; Ministry of Health Gaborone, Botswana.
Bapati W; Tebelopele Counseling and Testing Center, Gaborone, Botswana.
Segolodi T; US Centers for Disease Control and Prevention Botswana (CDC Botswana), Gaborone, Botswana.
Moore J; US Centers for Disease Control and Prevention Atlanta, United States.
Fonjungo PN; US Centers for Disease Control and Prevention Atlanta, United States. Electronic address: .
Pokaż więcej
Źródło:
Journal of virological methods [J Virol Methods] 2023 Jan; Vol. 311, pp. 114647. Date of Electronic Publication: 2022 Nov 04.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Point-of-Care Systems*
HIV Infections*/diagnosis
HIV Infections*/prevention & control
Humans ; Botswana ; Potassium Iodide ; CD4 Lymphocyte Count ; Health Personnel
Czasopismo naukowe
Szczegóły
Tytuł:
Attrition from Care Among Men Initiating ART in Male-Only Clinics Compared with Men in General Primary Healthcare Clinics in Khayelitsha, South Africa: A Matched Propensity Score Analysis.
Autorzy:
Cassidy T; Médecins Sans Frontières, 8 Mzala Street, 7784, Khayelitsha, Cape Town, South Africa. .; Division of Public Health Medicine, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa. .; Department of Epidemiology, Boston University School of Public Health, Boston, USA. .
Cornell M; Centre for Infectious Disease Epidemiology & Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Makeleni B; Médecins Sans Frontières, 8 Mzala Street, 7784, Khayelitsha, Cape Town, South Africa.
Horsburgh CR; Department of Epidemiology, Boston University School of Public Health, Boston, USA.; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, USA.; Department of Global Health, Boston University School of Public Health, Boston, USA.
Duran LT; Médecins Sans Frontières, 8 Mzala Street, 7784, Khayelitsha, Cape Town, South Africa.
de Azevedo V; City Health Department, Cape Town, South Africa.
Boulle A; Centre for Infectious Disease Epidemiology & Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.; Western Cape Provincial Department of Health, Cape Town, South Africa.
Fox MP; Department of Epidemiology, Boston University School of Public Health, Boston, USA.; Department of Global Health, Boston University School of Public Health, Boston, USA.; Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Pokaż więcej
Źródło:
AIDS and behavior [AIDS Behav] 2023 Jan; Vol. 27 (1), pp. 358-369. Date of Electronic Publication: 2022 Jul 31.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Humans ; Male ; Female ; Adult ; South Africa/epidemiology ; Propensity Score ; Primary Health Care ; CD4 Lymphocyte Count
Czasopismo naukowe
Szczegóły
Tytuł:
Comparative effects of 6-weeks progressive resistance exercise and moderate intensity aerobic exercise on CD4 count and weights of people living with HIV/AIDS in Alex-Ekwueme Federal University Teaching Hospital Ebonyi State.
Autorzy:
Asogwa EI; Department of Physiotherapy, Evangel University, Ebonyi State, Nigeria.
Abonyi OS; Faculty of Education, Ebonyi State University, Nigeria.
Elom CO; Alex Ekwueme Federal University, Ndufu Alike, Ebonyi State, Nigeria.
Oduma CA; Faculty of Education, Ebonyi State University, Nigeria.
Umoke CC; Alex Ekwueme Federal University, Ndufu Alike, Ebonyi State, Nigeria.
Ogai NA; Alex Ekwueme Federal University, Ndufu Alike, Ebonyi State, Nigeria.
Uwaleke CC; Alex Ekwueme Federal University, Ndufu Alike, Ebonyi State, Nigeria.
Nwimo IO; Faculty of Education, Ebonyi State University, Nigeria.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2022 Jan 14; Vol. 101 (2), pp. e28468.
Typ publikacji:
Journal Article
MeSH Terms:
Body Weight*
CD4 Lymphocyte Count*
Exercise Therapy*
HIV Infections*/therapy
Resistance Training*
Cell Differentiation ; Hospitals, Teaching ; Humans ; Pilot Projects ; Reproducibility of Results
Czasopismo naukowe
Szczegóły
Tytuł:
Effects of syphilis infection among HIV-1-positive individuals on suppressive antiretroviral therapy.
Autorzy:
Chan P; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.; Institute of HIV Research and Innovation, Bangkok, Thailand.
Tang THC; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
Kwong RTS; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
Chan L; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
Chan HSY; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
Lam KW; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
Ting WM; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
Yung SK; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
Lam ECT; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
Chu MY; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
Lam W; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
Wu TC; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
Li P; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.; Hong Kong Sanatorium & Hospital, Hong Kong, China.
Lee MP; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China. .
Pokaż więcej
Źródło:
AIDS research and therapy [AIDS Res Ther] 2022 Dec 31; Vol. 19 (1), pp. 69. Date of Electronic Publication: 2022 Dec 31.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/complications
HIV Infections*/drug therapy
HIV-1*
Syphilis*/epidemiology
HIV Seropositivity*/complications
Humans ; Male ; Reinfection/complications ; CD4-Positive T-Lymphocytes ; RNA ; Antiretroviral Therapy, Highly Active ; Viral Load ; CD4 Lymphocyte Count
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
High baseline body mass index predicts recovery of CD4+ T lymphocytes for HIV/AIDS patients receiving long-term antiviral therapy.
Autorzy:
Zhu J; Nursing College, Guangxi Medical University, Nanning, Guangxi, China.; The Second Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, China.
Huang H; Nursing College, Guangxi Medical University, Nanning, Guangxi, China.
Wang M; Nursing College, Guangxi Medical University, Nanning, Guangxi, China.
Zhang Y; Nursing College, Guangxi Medical University, Nanning, Guangxi, China.
Mo J; Nursing College, Guangxi Medical University, Nanning, Guangxi, China.; The Second Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, China.
Tian W; Nursing College, Guangxi Medical University, Nanning, Guangxi, China.
Tan S; Nursing College, Guangxi Medical University, Nanning, Guangxi, China.
Jiang L; Nursing College, Guangxi Medical University, Nanning, Guangxi, China.
Meng Z; Chest Hospital of Guangxi Zhuang Autonomous Region, Liuzhou, Guangxi, China.
Qin S; Chest Hospital of Guangxi Zhuang Autonomous Region, Liuzhou, Guangxi, China.
Ning C; Nursing College, Guangxi Medical University, Nanning, Guangxi, China.; The Second Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Dec 30; Vol. 17 (12), pp. e0279731. Date of Electronic Publication: 2022 Dec 30 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Acquired Immunodeficiency Syndrome*/drug therapy
HIV Infections*/drug therapy
Adult ; Humans ; Body Mass Index ; Retrospective Studies ; Antiretroviral Therapy, Highly Active ; China ; CD4-Positive T-Lymphocytes ; CD4 Lymphocyte Count ; Antiviral Agents/therapeutic use ; Viral Load
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 13216

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz